Research article · 29 Nov 2021
CommentaryPublished 25 Aug 2021
Methylprednisolone Administration
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Methylprednisolone is a synthetic glucocorticoid steroid that was created to have better anti-inflammatory and mineralocorticoid activity than cortisol, the prototype glucocorticoid steroid (hydrocortisone). As a glucocorticoid or antiinflammatory medication, methylprednisolone is about four times as effective as hydrocortisone, with around 0.8 times the amount of mineralocorticoid. Methylprednisolone also has a longer action time than hydrocortisone, with a plasma half-life of 2.5 hours compared to 1.5 hours for hydrocortisone. In the current treatment of MS, methylprednisolone is particularly crucial in the acute phase of recurrence. It reduces the inflammatory cycle in a variety of ways, including dampening the inflammatory cytokine cascade, inhibiting T cell activation, decreasing immune cell extravasation into the central nervous system, facilitating apoptosis of activated immune cells, and indirectly decreasing the cytotoxic effects of nitric oxide and TNF-a. As more information about these systems becomes available, it may become possible to develop therapy regimens that are better tailored to the individual as well as the disease state. The only effective neuroprotective drug studied in controlled multicentre clinical trials is high-dose methylprednisolone, as suggested by the National Acute Spinal Cord Injury Studies (NASCIS-2 and NASCIS-3). Methylprednisolone was studied as a lipid peroxidation inhibitor, with the goal of reducing posttraumatic degenerative alterations in the damaged spinal cord. However, several researchers and physicians have questioned the usefulness of methylprednisolone for the treatment of acute traumatic SCI due to inconsistent experimental data and the relatively tiny neurological benefits shown in humans
Subjects
Anaesthesia & PainAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Review article · 2015
Methylprednisolone Acetate Versus Triamcinolone Acetonide for Pain Relief in Spinal Nerve Root Block for Low Back Pain
Conference abstract · 4 Dec 2019
Comparison of intra-socket bupivacaine administration versus oral mefenamic acid capsule for postoperative pain management following removal of impacted mandibular third molars
Conference abstract · 4 Dec 2019
Comparison of intra-socket bupivacaine administration versus oral mefenamic acid capsule for postoperative pain management following removal of impacted mandibular third molars
Perspective · 21 Jun 2023
Essential Skills for Local Anaesthetic Administration in Dental Anaesthesia
More from this journal
The newest in Journal of Anesthesiology and Pain Research.
Opinion · 29 Dec 2025
Non-invasive Brain Stimulation for Chronic Pain
Article · 29 Dec 2025
Ethics of Pain Management: Consent, Equity, Opioids
Article · 29 Dec 2025
Anesthetic Management of Rare Pain Disorders
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Anesthesiology and Pain Research
- SubjectAnaesthesia & Pain
- BylineArticles whose byline prints “Khuong Lahn”

